Carlsmed, Inc. Common Stock (CARL) - Total Liabilities
Based on the latest financial reports, Carlsmed, Inc. Common Stock (CARL) has total liabilities worth $26.52 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Carlsmed, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Carlsmed, Inc. Common Stock - Total Liabilities Trend (2023–2025)
This chart illustrates how Carlsmed, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.
Carlsmed, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Carlsmed, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Taiwan Fire & Marine Insurance Co Ltd
TW:2832
|
Taiwan | NT$11.49 Billion |
|
Founders Metals Inc.
V:FDR
|
Canada | CA$8.87 Million |
|
Chemplast Sanmar Limited
NSE:CHEMPLASTS
|
India | Rs45.21 Billion |
|
INPAQ Technology Co Ltd
TWO:6284
|
Taiwan | NT$6.22 Billion |
|
Baader Bank Aktiengesellschaft
F:BWB
|
Germany | €4.09 Billion |
|
Jiangmen Kanhoo Industry Co Ltd
SHE:300340
|
China | CN¥2.41 Billion |
|
StealthGas Inc
NASDAQ:GASS
|
USA | $21.36 Million |
|
Shih Her Technologies
TWO:3551
|
Taiwan | NT$1.18 Billion |
Liability Composition Analysis (2023–2025)
This chart breaks down Carlsmed, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CARL stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 11.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Carlsmed, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Carlsmed, Inc. Common Stock (2023–2025)
The table below shows the annual total liabilities of Carlsmed, Inc. Common Stock from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $31.25 Million | -74.48% |
| 2024-12-31 | $122.45 Million | +103.57% |
| 2023-12-31 | $60.15 Million | -- |
About Carlsmed, Inc. Common Stock
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more